{"schema_version":"secwatch.filing_event.v1","accession":"0001789769-23-000095","form_type":"8-K","ticker":"TIL","cik":"0001789769","company_name":"Instil Bio, Inc.","filed_at":"2023-11-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.464202+00:00","generated_at":"2026-06-07T21:34:35.544331+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Instil Bio announces 1-for-20 reverse stock split approved by Audit Committee","bullets":["Audit Committee approved a 1-for-20 reverse stock split, with ratio determined per prior stockholder authorization.","Approval occurred on November 21, 2023; no effective date disclosed.","Reverse split follows annual meeting authorization at ratio range of 1-for-10 to 1-for-30."],"urls":{"canonical":"https://secwatch.observer/filing/0001789769-23-000095","json":"https://secwatch.observer/filing/0001789769-23-000095.json","markdown":"https://secwatch.observer/filing/0001789769-23-000095.md","text":"https://secwatch.observer/filing/0001789769-23-000095.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789769/000178976923000095/0001789769-23-000095-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789769/000178976923000095/til-20231121.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T21:34:35.544331+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}